Following his presentation at the ERS Congress, Dr. Kai-Michael Beeh (Insaf Respiratory Research Institute, Wiesbaden, Germany) caught up with us to continue the discussion around green inhalers.
1. Could you give us an overview of the environmental impact of asthma inhaler use? (0:22)
2. How do dry powder inhalers compare to metered-dose inhalers in terms of their carbon footprint? (0:54)
3. What factors should be considered when prescribing dry powder inhalers and how can we facilitate this process for patients? (1:23)
4. What would be the environmental impact if every asthma patient switched to a green inhaler? (1:59)
5. How can we further reduce the carbon footprint of asthma therapy? (2:36)
Speaker disclosure: The institutions Kai-Michael Beeh represents have received compensation for services on advisory boards or consulting from AstraZeneca, Berlin Chemie, Boehringer, Chiesi, GSK, Novartis, Pohl Boskamp, Teva and Sanofi. They have also received compensations for speaker activities in scientific meetings supported by AstraZeneca, Berlin Chemie, Boehringer, Chiesi, GSK, Novartis, Pohl Boskamp, Teva, Sanofi and compensation for design and performance of clinical trials from AstraZeneca, Boehringer, GSK, Novartis, Pearl Therapeutics, Teva and Stern.
Support: Interview and filming supported by Touch Medical Media.
Filmed in coverage of the ERS International Congress Congress 2020.
Share this Video
Related Videos In Asthma
Michael Wechsler, ERS 2020 – Dupilumab in the LIBERTY ASTHMA TRAVERSE Trial
We discuss with Prof. Michael Wechsler (National Jewish Health, Denver, CO, USA) the clinical evidence supporting the use of dupilumab in patients with asthma and specifically the major findings from the long-term safety evaluation of dupilumab in the LIBERTY ASTHMA TRAVERSE trial (NCT02134028). Questions 1. What are the major unmet needs in the biologic treatment […]
Richard van Zyl-Smit, ERS 2020 – Optimising Inhaled Therapies for Asthma
Richard van Zyl-Smit (University of Cape Town and Groote Schuur Hospital, Cape Town, South Africa) kindly took the time to speak with us about maximising the benefit of inhaler therapy and recent development being made in this field. Questions What are the major unmet needs in the use of inhaled therapies for the control of […]
Peter J Barnes, ERS 2020 – Smart Inhalers for COPD and Asthma
During the ERS International Congress 2020, it was great to catch up with our Editorial Board member, Prof. Peter J Barnes (Imperial College, London, UK), to continue the discussion around Smart Inhalers and how they could help optimise inhaler use in patients. Questions How common is poor adherence and inhaler technique in people with asthma […]
Journal articles and more to your inbox
Get the latest clinical insights from touchRESPIRATORYSign me up!